The NF-B pathway functions as a central pro-survival and pro-inflammatory transcription factor that promotes tumor progression by suppressing tumor suppressors such as phosphatase and tensin homolog (PTEN), thereby indirectly enhancing PI3K/AKT signaling and supporting cancer cell viability
Every patient begins with a comprehensive consultation to review health history, goals, and eligibility for GLP-1 therapy
The Best Strategy: Gradual Dose Reduction and Continuation Rather than stopping GLP-1 therapy cold, a tapering approachslowly reducing your dose over 4-8 weeksgives your body time to adjust
Originally developed for T2D, these agents enhance insulin sensitivity by reducing insulin resistance, as demonstrated by significant declines in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) scores
Using genetic insights, targeted peptide therapy, and regular lab tracking, her inflammatory markers dropped from dangerously high levels to normal, and her quality of life dramatically improved
While some patients report virtually no sensation, others may experience mild stinging or burning, particularly during initial injections